- Home
- EXEL vs SARO Comparison
EXEL vs SARO Comparison
Compare EXEL & SARO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- SARO
- Stock Information
- Founded
- EXEL 1994
- SARO 1911
- Country
- EXEL United States
- SARO United States
- Employees
- EXEL N/A
- SARO N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- SARO
- Sector
- EXEL Health Care
- SARO
- Exchange
- EXEL Nasdaq
- SARO NYSE
- Market Cap
- EXEL 9.7B
- SARO 10.9B
- IPO Year
- EXEL 2000
- SARO 2024
- Fundamental
- Price
- EXEL $34.45
- SARO $28.15
- Analyst Decision
- EXEL Buy
- SARO Buy
- Analyst Count
- EXEL 18
- SARO 8
- Target Price
- EXEL $31.72
- SARO $35.63
- AVG Volume (30 Days)
- EXEL 2.6M
- SARO 1.2M
- Earning Date
- EXEL 10-29-2024
- SARO 11-13-2024
- Dividend Yield
- EXEL N/A
- SARO N/A
- EPS Growth
- EXEL 441.02
- SARO N/A
- EPS
- EXEL 1.55
- SARO 0.07
- Revenue
- EXEL $2,081,598,000.00
- SARO $4,985,319,000.00
- Revenue This Year
- EXEL $20.53
- SARO $15.84
- Revenue Next Year
- EXEL $1.54
- SARO $12.22
- P/E Ratio
- EXEL $22.26
- SARO $459.99
- Revenue Growth
- EXEL 17.31
- SARO 20.11
- 52 Week Low
- EXEL $19.20
- SARO $26.78
- 52 Week High
- EXEL $36.60
- SARO $34.38
- Technical
- Relative Strength Index (RSI)
- EXEL 67.10
- SARO N/A
- Support Level
- EXEL $27.86
- SARO N/A
- Resistance Level
- EXEL $36.49
- SARO N/A
- Average True Range (ATR)
- EXEL 0.98
- SARO 0.00
- MACD
- EXEL -0.01
- SARO 0.00
- Stochastic Oscillator
- EXEL 74.10
- SARO 0.00
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About SARO STANDARDAERO INC.
StandardAero Inc is a provider of aftermarket services for fixed and rotary wing aircraft gas turbine engines and auxiliary power units (APUs) to the commercial, business, and military aircraft markets. It also provides aftermarket and upgrade services for business aviation and helicopter airframes and avionics. It operates in two segments Engine Services and Component Repair Services. The group generates the majority of its revenue from the Engine Services segment which provides engine and airframe maintenance, repair, overhaul, and related services to customers in the Commercial Aerospace, Military & Helicopter, and Business Aviation end markets.